AHCO vs. RDNT, BTSG, SHC, SGRY, VCYT, LFST, PRVA, CON, TDOC, and ARDT
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), LifeStance Health Group (LFST), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Teladoc Health (TDOC), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.
AdaptHealth vs.
AdaptHealth (NASDAQ:AHCO) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.
In the previous week, RadNet had 3 more articles in the media than AdaptHealth. MarketBeat recorded 4 mentions for RadNet and 1 mentions for AdaptHealth. RadNet's average media sentiment score of 1.06 beat AdaptHealth's score of 0.43 indicating that RadNet is being referred to more favorably in the news media.
AdaptHealth currently has a consensus target price of $12.20, suggesting a potential upside of 45.13%. RadNet has a consensus target price of $75.50, suggesting a potential upside of 26.88%. Given AdaptHealth's higher probable upside, equities analysts clearly believe AdaptHealth is more favorable than RadNet.
RadNet received 269 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.23% of users gave RadNet an outperform vote while only 61.31% of users gave AdaptHealth an outperform vote.
RadNet has lower revenue, but higher earnings than AdaptHealth. RadNet is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.
RadNet has a net margin of -0.25% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat RadNet's return on equity.
AdaptHealth has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 4.4% of AdaptHealth shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
RadNet beats AdaptHealth on 12 of the 19 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
This page (NASDAQ:AHCO) was last updated on 2/22/2025 by MarketBeat.com Staff
Free AHCO Stock Alerts